Navigation Links
Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units
Date:11/10/2008

I-ICE clinical study in mid-2009.

Another co-sponsored study is the Intravascular Cooling in the Treatment of Stroke -- Longer tPA window (ICTuS-L) study, which is a prospective, randomized, controlled, multi-center study, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS). The study is evaluating the safety and feasibility of InnerCool's endovascular temperature modulation therapy as an adjunctive treatment for acute ischemic stroke. The Company expects to announce results of this important safety study in 2009.

Cardium intends to advance InnerCool's portfolio of therapeutic cooling and warming products into vertical partnering opportunities with established companies having existing sales and marketing organizations but with a continuing need for innovative, high-value content products. The Company believes this distribution strategy is more cost-effective than establishing InnerCool as a fully integrated manufacturing, sales and marketing organization. At the same time, as noted above, InnerCool will continue to develop new and innovative products and is one of the few companies in the industry that continues to initiate cost-effective, sponsor-supported research efforts to broaden the understanding of the potential benefits of therapeutic temperature modulation therapy for advanced injury and disease.

Tissue Repair Company

Based on the clinical development timetable and the status of the current Phase 2b clinical study, Tissue Repair Company's product candidate, Excellarate(TM), which is a DNA-activated collagen gel for topical treatment formulated with an adenovector delivery carrier encoding human platelet-derived growth factor-BB (PDGF-BB), will be the central focus of Cardium's near-term clinical development programs. Excellarate is initially being developed to be administered only once or twice for the potential treatment of non-healing diabetic foot ulcers, compared to other treatments that require
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
2. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
3. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
4. Cardium Announces Follow-On Direct Investment by Institutional Investor
5. Cardium Selected for Inclusion in Russell Microcap Index
6. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
7. Cardium Launches New AWARE Clinical Study Website
8. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
9. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
10. Cardium Reports on First Quarter 2008 Highlights and Financial Results
11. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , , , , , , , , ... , , AUDIO: , A team of scien... University of Arizona, Cold Spring Harbor Laborat...ing the DNA of corn. The... , , C... , , , , , , , ...
(Date:11/20/2009)..., , SEATTLE, Nov. 20 /PRNewswire-FirstCal...announced that the U.S. Food and Drug Administrati... Company,s amended Biologics License Application (...te response. The FDA has assigned a Prescription ...which time it will respond to Dendreon,s amended B...
(Date:11/20/2009)..., , SEATTLE, Nov. 20 /PRNewswire-First... MTA: CTIC) announced today that the Ninth Circuit...rder and ruled that CTI should be allowed to pursu...g the case back to the District Court for trial. ...s former third-party reimbursement consultant for ...
(Date:11/19/2009)..., , Most people would like to be able to charge t...ickly and not too often. A recent discovery made b...tube-based supercapacitors that could do just this...hysics Letters , Prabhakar Bandaru, a professor in...ngineering, along with graduate student Mark Hoefe...
Breaking Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Nanotube defects equal better energy and storage systems 2
...Research Firm,s Services and ...ciQuest, Inc., the global leader,in helping academ...realize,the potential of strategic procurement, to... biopharmaceutical research and development,compan...automate,procurement functions for each of its mor...
...Group plc (AIM:,PRG), the international pharmaceut...s, Inc., a leader in the electronic transformation...day announce the formalization of a,partnership ag...new partnership combines Octagon,s expertise in el...sive clinical expertise across a,wide array of the...
...nal is a leader,in vision healthcare -- serving pe...ed for 103 years., According to Dr. Tara A Cortes... "This is a dramatic breakthrough in gene therapy ...seases that affect children.", According to Yocas...nal,who has Leber,s Congenital Amaurosis and whose...
Other Biology Technology:Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development 2Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership 2
(Date:11/22/2009)..., Census of Marine Life scientists have inventori...ution of deep sea species that have never known su... a frigid black world down to 5,000 meters (~3 mil...towed cameras, sonar and other vanguard technologi...arkness now number 17,650, a diverse collection of...
(Date:11/22/2009)..., Cambridge, MA November 23, 2009 Agios Pharmac...established, for the first time, that the mutated ...ith a cancer-causing gene, or oncogene. This break...DH1 produces a metabolite, 2-hydroxyglutarate (2HG...nant progression of gliomas, the most common type ...
(Date:11/20/2009)..., NJIT researchers are at work on many scientific... Foundation has recently provided support that tot... the following investigators under the American Re...searchers have been awarded grants for investigati...hed professor of physics, will enhance the capabil...
Breaking Biology News(10 mins):Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 1Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 2Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 3Help Save a Life Bone Marrow Donor Registry Drive Sept 2 at the Karmanos Cancer Center 55320 1Help Save a Life Bone Marrow Donor Registry Drive Sept 2 at the Karmanos Cancer Center 55320 2Help Save a Life Bone Marrow Donor Registry Drive Sept 2 at the Karmanos Cancer Center 55320 3Help Save a Life Bone Marrow Donor Registry Drive Sept 2 at the Karmanos Cancer Center 55320 4Saliva May Help Spot Oral Cancer Early 55317 1Saliva May Help Spot Oral Cancer Early 55317 2
...importance nowadays since it express who we are, b... individual from its form? The answer to that ques...et a group of scientists from the Universidad Naci...the USA, were able to address it, although motivat...he capacity to establish the function of a molecul...
... Health Organisation (WHO) has confirmed a low fre... 3 influenza seasons (2003 ?2006)1. , The infor...usceptibility Network in the WHO’s Weekly Epidemio...und 0.3% to oseltamivir was seen during the influe...amiflu use in Japan (35 million patients), the hig...
...apillomaviruses responsible for genital warts was ...lian of the Year 2006 Professor Ian Frazer and tri...ine , More than 200 patients in China and Austral...e Princess Alexandra (PA) Hospital. , "The new ...now if it improves the outcome after conventional ...
Other Biology News:WHO data confirms low level of resistance to Tamiflu 2WHO data confirms low level of resistance to Tamiflu 3
...XPRESS 2D Proteomic Imaging System, Professional P...n Over a Wide Dynamic Range: The ProXPRESS 2D Prot...ing system for both proteomic and general life sci...unparalleled flexibility, enabling the use of all ...
... T2-01 high-performance pump, available in a singl... efficiency dynamic valve design. With the most co...e, T2-01 is ideal for use in portable air and gas ... (T2-01 SH and T2-01TH). , Delivers 1.5 and 2.0 li...
...cription: ,Kit containing Dermal Fibroblasts (rab...taining 20% FBS and 10% DMSO at passage 25 (approx...This cell culture is supplied as a long-term cultu...onths of continuous growth from the date supplied,...
... containing Vaginal Keratinocyte Progenitors, Rabb...aining 20% FBS and 10% DMSO at passage 25 (approx)...his cell culture is supplied as a long-term cultur...nths of continuous growth from the date supplied, ...
Biology Products: